The FDA will require all immediate-release opioid pain killer packaging to carry strong warnings about risks for abuse, addiction, overdose, and death. (NPR) See Kristina Fiore's MedPage Today coverage here.

Heart disease funnels down across America over past 30 years, but Southern states still home to high risk. (STAT)

Toronto's infamous former mayor, Rob Ford, died at 46 after battle with pleomorphic liposarcoma. (Toronto Star)

The Supreme Court hears arguments today in a case testing whether religious non-profit employers opposed to providing contraceptive coverage must convey their objections to the federal government as required under the Affordable Care Act; doing so would allow their insurers to step in and provide coverage. (Christian Science Monitor)

AstraZeneca's stroke medication, Brilinta/Brilique, performed well in the SOCRATES trial, the pharmaceutical company reported. Check back later today for full MedPage Today coverage.

PCSK9 inhibitor, Praluent, shows promise in late-stage study in reducing the frequency of apheresis therapy, Sanofi and Regeneron report. (Reuters) But, a bigger issue may be Amgen's victory in a suit claiming Sanofi and Regeneron infringed on patents held by Amgen for Repatha, its PCSK9 entry. (Fierce Pharma)

Scarlet fever and measles cases continue to rise in the U.K.

Maybe "difficult" patients are just patients having "difficulties," Suzanne Gordon writes in the BMJ.

Maryland Health Benefit Exchange enrollees booted over clerical errors claiming insufficient payments short only a few cents.

Bristol-Myers Squibb to acquire Padlock Therapeutics Inc., a biotech firm known for its Protein/Peptidyl Arginine Deiminase (PAD) inhibitor discovery program and developments in rheumatoid arthritis and lupus medications.

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.